FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to combined drugs, and can be used for treating arterial hypertension. The drug is prepared by direct compression. A preparation with low residual humidity is more storage stable, shows high processibility and biological availability. The combined hypotensive drug contains a combination of enalapril maleate and hydrochlorthiazide as an agent, and lactose anhydride, microcrystalline cellulose, povidone, colloidal silicon dioxide, croscarmellose sodium and stearic acid salt as excipients. The optimum proportions of the components makes, wt %: The agent 11.0-18.0; Lactose anhydride 56.0-78.0; Microcrystalline cellulose 5.0-15.0; Povidone 2.0-4.0; Colloidal silicon dioxide 0.5-1.0; Magnesium stearate 0.5-1.0; Croscarmellose sodium 3.0-5.0.
EFFECT: making the drug preparation for treating arterial hypertension.
12 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ORAL PHARMACEUTICAL COMPOSITION OF DIURETICS AND ACE INHIBITOR IN MICRONIZED FORM, DRUG AND ITS APPLICATION | 2012 |
|
RU2618471C2 |
| STABLE PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE ACTION | 2007 |
|
RU2341254C1 |
| COMBINED HYPOTENSIVE AGENT | 2004 |
|
RU2266751C1 |
| COMBINED ANTIHYPERTENSIVE DRUG AND METHOD FOR PREPARING IT | 2011 |
|
RU2483728C1 |
| TWO-LAYERED TABLET FOR PREVENTING CARDIOVASCULAR DISTURBANCES, DRUG AND METHOD FOR PREVENTING CARDIOVASCULAR DISTURBANCES, INCLUDING APOPLEXY AND PARALYSIS BY USING SAID TABLET | 2007 |
|
RU2445088C2 |
| HYPOLIPIDEMIC DOSAGE FORM AND METHOD FOR PREPARING IT | 2013 |
|
RU2547574C2 |
| COMBINED MEDICATION FOR TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS | 2012 |
|
RU2558099C2 |
| PHARMACEUTICAL COMPOSITION IN FORM OF TABLET AND METHOD OF OBTAINING THEREOF | 2014 |
|
RU2546002C1 |
| DOSAGE FORM OF CLOPIDOGREL | 2013 |
|
RU2540519C2 |
| PHARMACEUTICAL COMPOSITION OF FABOMOTIZOLE DIHYDROCHLORIDE | 2022 |
|
RU2828872C2 |
